NVCR NovoCure PE ratio, current and historical analysis
The current PE ratio of NVCR can't be determined, as the TTM EPS of -$1.39 is negative. The most recent PE ratio recorded for NovoCure was 1101.5 in March 2021.
NVCR PE ratio history
Over the last nine years, the average PE ratio of NovoCure has been 609.94. Over the past nine years, NVCR's PE ratio was at its highest in the Mar 2021 quarter at 1,101.5, with a price of $132.18 and an EPS of $0.12. The Sep 2016 quarter recorded the bottom point at 6.83, with a price of $8.54 and an EPS of $1.25.
NovoCure PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | N/A | N/A | $14.93 | -$1.95 |
| 2022 | N/A | N/A | $73.35 | -$0.88 |
| 2021 | N/A | N/A | $75.08 | -$0.56 |
| 2020 | 865.2 | N/A | $173.04 | $0.2 |
| 2019 | N/A | N/A | $84.27 | -$0.07 |
| 2018 | N/A | N/A | $33.48 | -$0.69 |
| 2017 | N/A | N/A | $20.2 | -$0.7 |
| 2016 | N/A | N/A | $7.85 | -$1.54 |
| 2015 | N/A | N/A | $22.36 | -$3.67 |
| 2014 | N/A | N/A | N/A | -$6.46 |
| 2013 | N/A | N/A | N/A | -$6.73 |
NovoCure PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | N/A | N/A | $15.63 | -$1.39 |
| Jun 2024 | N/A | N/A | $17.13 | -$1.57 |
| Mar 2024 | N/A | N/A | $15.63 | -$1.8 |
| Dec 2023 | N/A | N/A | $14.93 | -$1.95 |
| Sep 2023 | N/A | N/A | $16.15 | -$1.85 |
| Jun 2023 | N/A | N/A | $41.5 | -$1.64 |
| Mar 2023 | N/A | N/A | $60.14 | -$1.33 |
| Dec 2022 | N/A | N/A | $73.35 | -$0.88 |
| Sep 2022 | N/A | N/A | $75.98 | -$0.77 |
| Jun 2022 | N/A | N/A | $69.5 | -$0.65 |
| Mar 2022 | N/A | N/A | $82.85 | -$0.56 |
| Dec 2021 | N/A | N/A | $75.08 | -$0.56 |
| Sep 2021 | N/A | N/A | $116.17 | -$0.26 |
| Jun 2021 | N/A | N/A | $221.82 | -$0.04 |
| Mar 2021 | 1,101.5 | 27.31% | $132.18 | $0.12 |
NVCR average PE ratio chart
NVCR PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| NBIX Neurocrine Biosciences Inc | 35.5 | $12.03B |
| NVAX Novavax Inc | N/A | $1.28B |
| NVCR NovoCure Ltd | N/A | $2.39B |
Frequently asked questions
What is NovoCure's PE ratio?
The current price to earnings ratio of NVCR can't be calculated, as its EPS of -$1.39 is negative.
What is the 5-year average PE ratio for NovoCure (NVCR)?
Over the last 5 years, the average price to earnings ratio for NVCR stock is 730.56.
What is the highest PE ratio for NVCR?
The highest quarterly PE ratio in the last nine years has been 1,101.5 and it was in the Mar 2021 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.